|
|||||
|
|
Plasma and tissue concentrations of fluconazole and their correlation to breakpoints |
|
| Authors: | L. Pittrow and A. Penk |
| Affiliation: | Pfizer GmbH, Abt. Medizin, Karlsruhe, Germany |
| Abstract: | |
| Keywords: | Fluconazole plasma concentrations tissue concentrations antimycotic chemotherapy clinical outcome antifungal susceptibility testing NCCLS M27-T standard breakpoints immunostatus Fluconazol Plasmakonzentrationen Gewebekonzentrationen antimykotische Chemotherapie klinisches Therapieergebnis Antimykotika-Empfindlichkeitsprüfung NCCLS M27-T-Standard Breakpoints Immunstatus |